SCHEMBL5338189

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL5344753	0.95	P2RY12 (0.70)	TERTP2RY12
	SCHEMBL31312543	0.90	TERT (0.76)	TERTP2RY12MAOA
	SCHEMBL5333828	0.88	P2RY12 (0.72)	TERTP2RY12CASP3CASP2CASP7
	SCHEMBL5337682	0.82	TERT (1.00)	TERTP2RY12MAOA
	SCHEMBL5337185	0.80	TERT (1.00)	TERTP2RY12MAOA
	SCHEMBL5339762	0.79	TERT (1.00)	TERT
	SCHEMBL5336710	0.78	TERT (1.00)	TERT
	SCHEMBL14355637	0.76	TERT (1.00)	TERT
	SCHEMBL5341618	0.76	TERT (1.00)	TERT
	SCHEMBL5335580	0.75	TERT (1.00)	TERT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.